{
  "DOI": "10.1007/s00439-011-0990-0",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-011-0990-0",
  "alternative-id": [
    "990"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pajic",
      "given": "Marina",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Scarlett",
      "given": "Christopher J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chang",
      "given": "David K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sutherland",
      "given": "Robert L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Biankin",
      "given": "Andrew V.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        4,
        22
      ]
    ],
    "date-time": "2011-04-22T10:49:41Z",
    "timestamp": 1303469381000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        11,
        22
      ]
    ],
    "date-time": "2021-11-22T01:03:05Z",
    "timestamp": 1637542985000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T06:00:55Z",
    "timestamp": 1700632855384
  },
  "is-referenced-by-count": 13,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2011,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            4,
            23
          ]
        ],
        "date-time": "2011-04-23T00:00:00Z",
        "timestamp": 1303516800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-011-0990-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-011-0990-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-011-0990-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "93-101",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1371/journal.pcbi.0030225",
      "author": "N Beerenwinkel",
      "doi-asserted-by": "crossref",
      "first-page": "e225",
      "journal-title": "PLoS Comput Biol",
      "key": "990_CR1",
      "unstructured": "Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Vogelstein B, Nowak MA (2007) Genetic progression and the waiting time to cancer. PLoS Comput Biol 3:e225",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2008.20.8397",
      "author": "C Bokemeyer",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "journal-title": "J Clin Oncol",
      "key": "990_CR2",
      "unstructured": "Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G, Stroh C, Loos AH, Zubel A, Koralewski P (2009) Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 27:663–671",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-008-0128-9",
      "author": "T Byrski",
      "doi-asserted-by": "crossref",
      "first-page": "359",
      "journal-title": "Breast Cancer Res Treat",
      "key": "990_CR3",
      "unstructured": "Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA (2009) Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 115:359–363",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1002/pbc.22352",
      "author": "H Carol",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "journal-title": "Pediatr Blood Cancer",
      "key": "990_CR4",
      "unstructured": "Carol H, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Maris JM, Keir ST, Watkins A, Smith MA, Lock RB (2010) Initial testing of topotecan by the pediatric preclinical testing program. Pediatr Blood Cancer 54:707–715",
      "volume": "54",
      "year": "2010"
    },
    {
      "DOI": "10.1038/scientificamerican0307-50",
      "author": "FS Collins",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "journal-title": "Sci Am",
      "key": "990_CR5",
      "unstructured": "Collins FS, Barker AD (2007) Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am 296:50–57",
      "volume": "296",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nm1107-1276b",
      "doi-asserted-by": "crossref",
      "key": "990_CR6",
      "unstructured": "Coombes KR, Wang J, Baggerly KA (2007) Microarrays: retracing steps. Nat Med 13:1276–1277 (author reply 1277–1278)"
    },
    {
      "DOI": "10.1056/NEJMra072367",
      "author": "CM Croce",
      "doi-asserted-by": "crossref",
      "first-page": "502",
      "journal-title": "N Engl J Med",
      "key": "990_CR7",
      "unstructured": "Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502–511",
      "volume": "358",
      "year": "2008"
    },
    {
      "author": "R Dagher",
      "first-page": "3034",
      "journal-title": "Clin Cancer Res",
      "key": "990_CR8",
      "unstructured": "Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, Pazdur R (2002) Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 8:3034–3038",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1038/44413",
      "author": "D Dickson",
      "doi-asserted-by": "crossref",
      "first-page": "729",
      "journal-title": "Nature",
      "key": "990_CR9",
      "unstructured": "Dickson D (1999) Wellcome funds cancer database. Nature 401:729",
      "volume": "401",
      "year": "1999"
    },
    {
      "DOI": "10.1056/NEJM200104053441402",
      "author": "BJ Druker",
      "doi-asserted-by": "crossref",
      "first-page": "1038",
      "journal-title": "N Engl J Med",
      "key": "990_CR10",
      "unstructured": "Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001a) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038–1042",
      "volume": "344",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM200104053441401",
      "author": "BJ Druker",
      "doi-asserted-by": "crossref",
      "first-page": "1031",
      "journal-title": "N Engl J Med",
      "key": "990_CR11",
      "unstructured": "Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL (2001b) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031–1037",
      "volume": "344",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.1999.17.6.1815",
      "author": "WL Furman",
      "doi-asserted-by": "crossref",
      "first-page": "1815",
      "journal-title": "J Clin Oncol",
      "key": "990_CR12",
      "unstructured": "Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC, Bowman LC, Ma MK, Hoffer FA, Meyer WH, Pappo AS, Walter AW, Houghton PJ (1999) Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol 17:1815–1824",
      "volume": "17",
      "year": "1999"
    },
    {
      "DOI": "10.1126/science.7939630",
      "author": "PA Futreal",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "journal-title": "Science",
      "key": "990_CR13",
      "unstructured": "Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.1200/JCO.20.6.1692",
      "author": "MC Heinrich",
      "doi-asserted-by": "crossref",
      "first-page": "1692",
      "journal-title": "J Clin Oncol",
      "key": "990_CR14",
      "unstructured": "Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692–1703",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2005.02.840",
      "author": "RS Herbst",
      "doi-asserted-by": "crossref",
      "first-page": "5892",
      "journal-title": "J Clin Oncol",
      "key": "990_CR15",
      "unstructured": "Herbst RS, Prager D, Hermann R, Fehrenbacher L, Johnson BE, Sandler A, Kris MG, Tran HT, Klein P, Li X, Ramies D, Johnson DH, Miller VA (2005) TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 23:5892–5899",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature08987",
      "author": "ICGC Consortium",
      "doi-asserted-by": "crossref",
      "first-page": "993",
      "journal-title": "Nature",
      "key": "990_CR16",
      "unstructured": "ICGC Consortium (2010) International network of cancer genome projects. Nature 464:993–998",
      "volume": "464",
      "year": "2010"
    },
    {
      "DOI": "10.1182/blood-2001-12-0207",
      "author": "M Ito",
      "doi-asserted-by": "crossref",
      "first-page": "3175",
      "journal-title": "Blood",
      "key": "990_CR17",
      "unstructured": "Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182",
      "volume": "100",
      "year": "2002"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-3586",
      "author": "A Jimeno",
      "doi-asserted-by": "crossref",
      "first-page": "3003",
      "journal-title": "Cancer Res",
      "key": "990_CR18",
      "unstructured": "Jimeno A, Rubio-Viqueira B, Amador ML, Oppenheimer D, Bouraoud N, Kulesza P, Sebastiani V, Maitra A, Hidalgo M (2005) Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents. Cancer Res 65:3003–3010",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1054/bjoc.2001.1796",
      "author": "JI Johnson",
      "doi-asserted-by": "crossref",
      "first-page": "1424",
      "journal-title": "Br J Cancer",
      "key": "990_CR19",
      "unstructured": "Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424–1431",
      "volume": "84",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1171202",
      "author": "S Jones",
      "doi-asserted-by": "crossref",
      "first-page": "217",
      "journal-title": "Science",
      "key": "990_CR20",
      "unstructured": "Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217",
      "volume": "324",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2007-03-080325",
      "author": "MH Kang",
      "doi-asserted-by": "crossref",
      "first-page": "2057",
      "journal-title": "Blood",
      "key": "990_CR21",
      "unstructured": "Kang MH, Kang YH, Szymanska B, Wilczynska-Kalak U, Sheard MA, Harned TM, Lock RB, Reynolds CP (2007) Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 110:2057–2066",
      "volume": "110",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa055104",
      "author": "H Kantarjian",
      "doi-asserted-by": "crossref",
      "first-page": "2542",
      "journal-title": "N Engl J Med",
      "key": "990_CR22",
      "unstructured": "Kantarjian H, Giles F, Wunderle L, Bhalla K, O’Brien S, Wassmann B, Tanaka C, Manley P, Rae P, Mietlowski W, Bochinski K, Hochhaus A, Griffin JD, Hoelzer D, Albitar M, Dugan M, Cortes J, Alland L, Ottmann OG (2006) Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N Engl J Med 354:2542–2551",
      "volume": "354",
      "year": "2006"
    },
    {
      "DOI": "10.1023/B:CLIN.0000017160.93812.3b",
      "author": "MH Katz",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "journal-title": "Clin Exp Metastasis",
      "key": "990_CR23",
      "unstructured": "Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M (2004) An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis 21:7–12",
      "volume": "21",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nprot.2009.171",
      "author": "MP Kim",
      "doi-asserted-by": "crossref",
      "first-page": "1670",
      "journal-title": "Nat Protoc",
      "key": "990_CR24",
      "unstructured": "Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE (2009) Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc 4:1670–1680",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2005.01.9661",
      "author": "HL Kindler",
      "doi-asserted-by": "crossref",
      "first-page": "8033",
      "journal-title": "J Clin Oncol",
      "key": "990_CR25",
      "unstructured": "Kindler HL, Friberg G, Singh DA, Locker G, Nattam S, Kozloff M, Taber DA, Karrison T, Dachman A, Stadler WM, Vokes EE (2005) Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 23:8033–8040",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1093/annonc/mdp496",
      "author": "C Larbouret",
      "doi-asserted-by": "crossref",
      "first-page": "98",
      "journal-title": "Ann Oncol",
      "key": "990_CR26",
      "unstructured": "Larbouret C, Robert B, Bascoul-Mollevi C, Penault-Llorca F, Ho-Pun-Cheung A, Morisseau S, Navarro-Teulon I, Mach JP, Pelegrin A, Azria D (2010) Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Ann Oncol 21:98–103",
      "volume": "21",
      "year": "2010"
    },
    {
      "DOI": "10.1080/10428190601113584",
      "author": "EM Lee",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "journal-title": "Leuk Lymphoma",
      "key": "990_CR27",
      "unstructured": "Lee EM, Bachmann PS, Lock RB (2007a) Xenograft models for the preclinical evaluation of new therapies in acute leukemia. Leuk Lymphoma 48:659–668",
      "volume": "48",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0610292104",
      "author": "JK Lee",
      "doi-asserted-by": "crossref",
      "first-page": "13086",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "990_CR28",
      "unstructured": "Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D (2007b) A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci USA 104:13086–13091",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.5694/j.1326-5377.2009.tb02592.x",
      "author": "CK Lee",
      "doi-asserted-by": "crossref",
      "first-page": "631",
      "journal-title": "Med J Aust",
      "key": "990_CR29",
      "unstructured": "Lee CK, Lord SJ, Coates AS, Simes RJ (2009) Molecular biomarkers to individualise treatment: assessing the evidence. Med J Aust 190:631–636",
      "volume": "190",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jnci/87.15.1114",
      "author": "G Marra",
      "doi-asserted-by": "crossref",
      "first-page": "1114",
      "journal-title": "J Natl Cancer Inst",
      "key": "990_CR30",
      "unstructured": "Marra G, Boland CR (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114–1125",
      "volume": "87",
      "year": "1995"
    },
    {
      "DOI": "10.1126/science.306.5696.630",
      "author": "E Marshall",
      "doi-asserted-by": "crossref",
      "first-page": "630",
      "journal-title": "Science",
      "key": "990_CR31",
      "unstructured": "Marshall E (2004) Getting the noise out of gene arrays. Science 306:630–631",
      "volume": "306",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-09-0075",
      "author": "WA Messersmith",
      "doi-asserted-by": "crossref",
      "first-page": "1484",
      "journal-title": "Mol Cancer Ther",
      "key": "990_CR32",
      "unstructured": "Messersmith WA, Rajeshkumar NV, Tan AC, Wang XF, Diesl V, Choe SE, Follettie M, Coughlin C, Boschelli F, Garcia-Garcia E, Lopez-Rios F, Jimeno A, Hidalgo M (2009) Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol Cancer Ther 8:1484–1493",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1146/annurev-genet-102108-134222",
      "author": "GL Moldovan",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "journal-title": "Annu Rev Genet",
      "key": "990_CR33",
      "unstructured": "Moldovan GL, D’Andrea AD (2009) How the Fanconi anemia pathway guards the genome. Annu Rev Genet 43:223–249",
      "volume": "43",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-0261",
      "author": "J Mullenders",
      "doi-asserted-by": "crossref",
      "first-page": "5811",
      "journal-title": "Clin Cancer Res",
      "key": "990_CR34",
      "unstructured": "Mullenders J, von der Saal W, van Dongen MM, Reiff U, van Willigen R, Beijersbergen RL, Tiefenthaler G, Klein C, Bernards R (2009) Candidate biomarkers of response to an experimental cancer drug identified through a large-scale RNA interference genetic screen. Clin Cancer Res 15:5811–5819",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1126/science.1171362",
      "author": "KP Olive",
      "doi-asserted-by": "crossref",
      "first-page": "1457",
      "journal-title": "Science",
      "key": "990_CR35",
      "unstructured": "Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Ruckert F, Grutzmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457–1461",
      "volume": "324",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa041588",
      "author": "S Paik",
      "doi-asserted-by": "crossref",
      "first-page": "2817",
      "journal-title": "N Engl J Med",
      "key": "990_CR36",
      "unstructured": "Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826",
      "volume": "351",
      "year": "2004"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-0041",
      "author": "M Pajic",
      "doi-asserted-by": "crossref",
      "first-page": "6396",
      "journal-title": "Cancer Res",
      "key": "990_CR37",
      "unstructured": "Pajic M, Iyer JK, Kersbergen A, van der Burg E, Nygren AO, Jonkers J, Borst P, Rottenberg S (2009) Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. Cancer Res 69:6396–6404",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.0405220101",
      "author": "W Pao",
      "doi-asserted-by": "crossref",
      "first-page": "13306",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "990_CR38",
      "unstructured": "Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H (2004) EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306–13311",
      "volume": "101",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-3191",
      "author": "TM Pitts",
      "doi-asserted-by": "crossref",
      "first-page": "3193",
      "journal-title": "Clin Cancer Res",
      "key": "990_CR39",
      "unstructured": "Pitts TM, Tan AC, Kulikowski GN, Tentler JJ, Brown AM, Flanigan SA, Leong S, Coldren CD, Hirsch FR, Varella-Garcia M, Korch C, Eckhardt SG (2010) Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development. Clin Cancer Res 16:3193–3204",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature07567",
      "author": "E Quintana",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "journal-title": "Nature",
      "key": "990_CR41",
      "unstructured": "Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593–598",
      "volume": "456",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.0702955104",
      "author": "S Rottenberg",
      "doi-asserted-by": "crossref",
      "first-page": "12117",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "990_CR42",
      "unstructured": "Rottenberg S, Nygren AO, Pajic M, van Leeuwen FW, van der Heijden I, van de Wetering K, Liu X, de Visser KE, Gilhuijs KG, van Tellingen O, Schouten JP, Jonkers J, Borst P (2007) Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci USA 104:12117–12122",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0806092105",
      "author": "S Rottenberg",
      "doi-asserted-by": "crossref",
      "first-page": "17079",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "990_CR43",
      "unstructured": "Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, Derksen PW, de Bruin M, Zevenhoven J, Lau A, Boulter R, Cranston A, O’Connor MJ, Martin NM, Borst P, Jonkers J (2008) High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci USA 105:17079–17084",
      "volume": "105",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0113",
      "author": "B Rubio-Viqueira",
      "doi-asserted-by": "crossref",
      "first-page": "4652",
      "journal-title": "Clin Cancer Res",
      "key": "990_CR44",
      "unstructured": "Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H, Tanaka K, Singh S, Salimi-Moosavi H, Bouraoud N, Amador ML, Altiok S, Kulesza P, Yeo C, Messersmith W, Eshleman J, Hruban RH, Maitra A, Hidalgo M (2006) An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12:4652–4661",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nbt.1640",
      "author": "M Singh",
      "doi-asserted-by": "crossref",
      "first-page": "585",
      "journal-title": "Nat Biotechnol",
      "key": "990_CR45",
      "unstructured": "Singh M, Lima A, Molina R, Hamilton P, Clermont AC, Devasthali V, Thompson JD, Cheng JH, Bou Reslan H, Ho CC, Cao TC, Lee CV, Nannini MA, Fuh G, Carano RA, Koeppen H, Yu RX, Forrest WF, Plowman GD, Johnson L (2010) Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. Nat Biotechnol 28:585–593",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJM200103153441101",
      "author": "DJ Slamon",
      "doi-asserted-by": "crossref",
      "first-page": "783",
      "journal-title": "N Engl J Med",
      "key": "990_CR46",
      "unstructured": "Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783–792",
      "volume": "344",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.191368598",
      "author": "JE Staunton",
      "doi-asserted-by": "crossref",
      "first-page": "10787",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "990_CR47",
      "unstructured": "Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES, Golub TR (2001) Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98:10787–10792",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nrd1984",
      "author": "G Szakacs",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "journal-title": "Nat Rev Drug Discov",
      "key": "990_CR48",
      "unstructured": "Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa055229",
      "author": "M Talpaz",
      "doi-asserted-by": "crossref",
      "first-page": "2531",
      "journal-title": "N Engl J Med",
      "key": "990_CR49",
      "unstructured": "Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R, Cortes J, O’Brien S, Nicaise C, Bleickardt E, Blackwood-Chirchir MA, Iyer V, Chen TT, Huang F, Decillis AP, Sawyers CL (2006) Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 354:2531–2541",
      "volume": "354",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nature07385",
      "author": "TCGA Network",
      "doi-asserted-by": "crossref",
      "first-page": "1061",
      "journal-title": "Nature",
      "key": "990_CR50",
      "unstructured": "TCGA Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMoa021967",
      "author": "MJ Vijver van de",
      "doi-asserted-by": "crossref",
      "first-page": "1999",
      "journal-title": "N Engl J Med",
      "key": "990_CR51",
      "unstructured": "van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009",
      "volume": "347",
      "year": "2002"
    },
    {
      "DOI": "10.1038/415530a",
      "author": "LJ Van’t Veer",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "journal-title": "Nature",
      "key": "990_CR52",
      "unstructured": "Van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536",
      "volume": "415",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.20.3.719",
      "author": "CL Vogel",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "journal-title": "J Clin Oncol",
      "key": "990_CR53",
      "unstructured": "Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20:719–726",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1038/378789a0",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "journal-title": "Nature",
      "key": "990_CR54",
      "unstructured": "Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792",
      "volume": "378",
      "year": "1995"
    },
    {
      "DOI": "10.1038/ng1942",
      "author": "B Xia",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "journal-title": "Nat Genet",
      "key": "990_CR55",
      "unstructured": "Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159–161",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/90.7.505",
      "author": "WC Zamboni",
      "doi-asserted-by": "crossref",
      "first-page": "505",
      "journal-title": "J Natl Cancer Inst",
      "key": "990_CR56",
      "unstructured": "Zamboni WC, Stewart CF, Thompson J, Santana VM, Cheshire PJ, Richmond LB, Luo X, Poquette C, Houghton JA, Houghton PJ (1998) Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst 90:505–511",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-3367",
      "author": "SA Zander",
      "doi-asserted-by": "crossref",
      "first-page": "1700",
      "journal-title": "Cancer Res",
      "key": "990_CR57",
      "unstructured": "Zander SA, Kersbergen A, van der Burg E, de Water N, van Tellingen O, Gunnarsdottir S, Jaspers JE, Pajic M, Nygren AO, Jonkers J, Borst P, Rottenberg S (2010) Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan. Cancer Res 70:1700–1710",
      "volume": "70",
      "year": "2010"
    }
  ],
  "reference-count": 56,
  "references-count": 56,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-011-0990-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes"
  ],
  "type": "journal-article",
  "volume": "130"
}